Finance

Lists
CORONA:NSE
Corona Remedies Ltd
2 020,10 INR
-1,21%
(-24,70) 1D
16 ოქტ, 14:36:38 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for CORONA...
Open
2 044,40 INR
High
2 065,40 INR
Low
1 995,00 INR
Mkt. cap
123,39 მლრ.
Avg. vol.
43,96 ათ.
Volume
100,24 ათ.
Dividend
0,50%
Quarterly dividend
2,50 INR
Ex-dividend date
19 ივნ. 2026
P/E ratio
62,08
52-wk high
2 292,40 INR
52-wk low
1 336,60 INR
EPS
32,54 INR
No. of employees
5 ათ.
Open
2 044,40 INR
High
2 065,40 INR
Low
1 995,00 INR
Mkt. cap
123,39 მლრ.
Avg. vol.
43,96 ათ.
Volume
100,24 ათ.
Dividend
0,50%
Quarterly dividend
2,50 INR
Ex-dividend date
19 ივნ. 2026
P/E ratio
62,08
52-wk high
2 292,40 INR
52-wk low
1 336,60 INR
EPS
32,54 INR
No. of employees
5 ათ.
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
30 წუთის წინ
Pega Stock Gets Analyst Backing Ahead Of Results
Investor's Business Daily
Investor's Business Daily
·
5 საათის წინ
Futures Mixed; Anthropic Value, Tesla Roadster In Focus
About Corona Remedies Ltd
CEO-
Employees5,15 ათ.
Founded2004
Headquarters-
SectorPharmaceutical industry
Last report
31 ივლ. 2026
Fiscal period
Q1 2027
9,83 INR / 9,20 INR
+6,85%beat
Revenue / Est. (INR)
4,22 მლრდ. / 4,04 მლრდ.
+4,64%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
3,61 მლრდ.
3,42 მლრდ.
3,53 მლრდ.
4,22 მლრდ.
Cost of goods sold
686,50 მლნ.
602,70 მლნ.
772,40 მლნ.
775,20 მლნ.
Cost of revenue
686,50 მლნ.
602,70 მლნ.
772,40 მლნ.
775,20 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,03 მლრდ.
959,40 მლნ.
2,14 მლრდ.
1,22 მლრდ.
Operating expense
2,23 მლრდ.
2,08 მლრდ.
2,24 მლრდ.
2,65 მლრდ.
Total operating expenses
2,92 მლრდ.
2,69 მლრდ.
3,01 მლრდ.
3,43 მლრდ.
Operating income
692,70 მლნ.
737,10 მლნ.
522,70 მლნ.
798,90 მლნ.
Other non operating income
22,70 მლნ.
22,40 მლნ.
-58,90 მლნ.
31,50 მლნ.
EBT including unusual items
697,80 მლნ.
552,10 მლნ.
547,40 მლნ.
803,60 მლნ.
EBT excluding unusual items
697,80 მლნ.
743,10 მლნ.
550,20 მლნ.
803,60 მლნ.
Income tax expense
174,60 მლნ.
139,40 მლნ.
94,10 მლნ.
202,50 მლნ.
Effective tax rate
25,02%
25,25%
17,19%
25,20%
Other operating expenses
1,11 მლრდ.
1,03 მლრდ.
-7,00 მლნ.
1,30 მლრდ.
Net income
523,20 მლნ.
412,70 მლნ.
453,30 მლნ.
601,10 მლნ.
Net profit margin
14,49%
12,05%
12,84%
14,23%
Earnings per share
-
-
7,41
9,83
Interest and investment income
-
-
70,60 მლნ.
-
Interest expense
-19,30 მლნ.
-16,60 მლნ.
-11,10 მლნ.
-26,90 მლნ.
Net interest expenses
-19,30 მლნ.
-16,60 მლნ.
59,50 მლნ.
-26,90 მლნ.
Depreciation and amortization charges
92,00 მლნ.
94,50 მლნ.
102,90 მლნ.
132,40 მლნ.
EBITDA
794,16 მლნ.
838,56 მლნ.
608,10 მლნ.
884,30 მლნ.
Gain or loss from assets sale
2,61 მლნ.
-
-
-
AI content may include mistakes. Learn more
Google აპები